Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / *W EXP 99/99/999
-
Total 13F shares
-
2,281,964
-
Share change
-
+2,281,964
-
Total reported value
-
$1,913,061
-
Price per share
-
$0.8667
-
Number of holders
-
20
-
Value change
-
+$1,913,061
-
Number of buys
-
20
Institutional Holders of NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW) as of Q4 2022
As of 31 Dec 2022 NewAmsterdam Pharma Co N.V. - *W EXP 99/99/999 (NAMSW) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,281,964 shares of stock of the company.
Largest 10 holders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, Frazier Life Sciences Management, L.P., RA CAPITAL MANAGEMENT, L.P., Ensign Peak Advisors, Inc, Exos TFP Holdings LLC, Bain Capital Life Sciences Investors, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Castle Creek Arbitrage, LLC, PEAK6 Investments LLC, and Westchester Capital Management, LLC.
This table shows 20 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.